Indication CINRYZE® (C1 esterase inhibitor [human]) is indicated for routine prophylaxis against angioedema attacks in adults, adolescents and pediatric patients (6 years of age and older) with Hereditary Angioedema (HAE).
OnePath provides product support based on individual patient needs.
1. Complete and fax the following to 1-855-ONEPATH (1-855-663-7284):
OnePath Start Form
In order for OnePath to provide services to your patient, the patient will need to sign the OnePath Start Form, which provides their consent for services. Download the English version now
A copy of your patient's insurance card(s)
2. Next a OnePath Patient Support Manager will facilitate a benefits investigation.
If your patient does not have insurance coverage, a OnePath Patient Support Manager will work with your patient to provide information about their options.
3. The Patient Support Manager will forward the prescription to a specialty pharmacy that will dispense CINRYZE.
Note that insurance companies sometimes require additional documentation to authorize coverage for CINRYZE, which could include a Statement of Medical Necessity.
For more information about the OnePath program, call 1-866-888-0660. OnePath is available Monday through Friday from 8:30 AM to 8:00 PM ET